Literature DB >> 15727121

Chimerization of multiple antibody classes using splice overlap extension PCR.

Martina L Jones1, Ross T Barnard.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15727121     DOI： 10.2144/05382BM01

Source DB:  PubMed          Journal:  Biotechniques        ISSN： 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  10 in total

1.  Virus-induced gene silencing for comparative functional studies in Gladiolus hybridus.

Authors:  Xionghui Zhong; Xue Yuan; Ze Wu; Muhammad Ali Khan; Jin Chen; Xiaoxin Li; Benhe Gong; Yang Zhao; Jian Wu; Chenyu Wu; Mingfang Yi
Journal:  Plant Cell Rep       Date:  2013-10-30       Impact factor: 4.570

2.  CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Authors:  Phillip D Fromm; Michael S Papadimitrious; Jennifer L Hsu; Nicolas Van Kooten Losio; Nirupama D Verma; Tsun Ho Lo; Pablo A Silveira; Christian E Bryant; Cameron J Turtle; Rebecca L Prue; Peter Vukovic; David J Munster; Tomoko Nagasaki; Ross T Barnard; Stephen M Mahler; Sébastien A Anguille; Zwi Berneman; Lisa G Horvath; Kenneth F Bradstock; Douglas E Joshua; Georgina J Clark; Derek N J Hart
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

3.  Engineering Escherichia coli for high-level production of propionate.

Authors:  Lamees Akawi; Kajan Srirangan; Xuejia Liu; Murray Moo-Young; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2015-05-07       Impact factor: 3.346

4.  Engineering Escherichia coli for Microbial Production of Butanone.

Authors:  Kajan Srirangan; Xuejia Liu; Lamees Akawi; Mark Bruder; Murray Moo-Young; C Perry Chou
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

5.  Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.

Authors:  Jerome E Tanner; Mathieu Coinçon; Valérie Leblond; Jing Hu; Janey M Fang; Jurgen Sygusch; Caroline Alfieri
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

6.  Gene therapy of malignant solid tumors by targeting erbB2 receptors and by activating T cells.

Authors:  Wang-Xiong Hu; He-Ping Chen; Kang Yu; Lu-Xi Shen; Chao-Yan Wang; Shi-Zhen Su; Wen-Jun Sui; Da-Ming Shan; Hong-Zhi Li
Journal:  Cancer Biother Radiopharm       Date:  2012-09-18       Impact factor: 3.099

7.  Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by Orientia tsutsugamushi).

Authors:  Martina L Jones; Ross T Barnard
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

8.  Manipulating the sleeping beauty mutase operon for the production of 1-propanol in engineered Escherichia coli.

Authors:  Kajan Srirangan; Lamees Akawi; Xuejia Liu; Adam Westbrook; Eric Jm Blondeel; Marc G Aucoin; Murray Moo-Young; C Perry Chou
Journal:  Biotechnol Biofuels       Date:  2013-09-28       Impact factor: 6.040

9.  Engineering of Escherichia coli for direct and modulated biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer using unrelated carbon sources.

Authors:  Kajan Srirangan; Xuejia Liu; Tam T Tran; Trevor C Charles; Murray Moo-Young; C Perry Chou
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

10.  Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013.

Authors:  Jinding Chen; Mingqiu Zhao; Wenhui Li; Dijing Zhuang; Hong Li; Mengpo Zhao; Erpeng Zhu; Baoming Xie
Journal:  BMC Vet Res       Date:  2021-04-14       Impact factor: 2.741
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.